These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31279989)

  • 61. Contrast-enhanced spectral mammography (CESM) versus breast magnetic resonance imaging (MRI): A retrospective comparison in 66 breast lesions.
    Li L; Roth R; Germaine P; Ren S; Lee M; Hunter K; Tinney E; Liao L
    Diagn Interv Imaging; 2017 Feb; 98(2):113-123. PubMed ID: 27687829
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Acute Adverse Events Following Gadolinium-based Contrast Agent Administration: A Single-Center Retrospective Study of 281 945 Injections.
    McDonald JS; Hunt CH; Kolbe AB; Schmitz JJ; Hartman RP; Maddox DE; Kallmes DF; McDonald RJ
    Radiology; 2019 Sep; 292(3):620-627. PubMed ID: 31264948
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Contrast-enhanced cone-beam breast-CT (CBBCT): clinical performance compared to mammography and MRI.
    Wienbeck S; Fischer U; Luftner-Nagel S; Lotz J; Uhlig J
    Eur Radiol; 2018 Sep; 28(9):3731-3741. PubMed ID: 29594402
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Use of diagnostic dynamic contrast-enhanced (DCE)-MRI for targeting of soft tissue tumour biopsies at 3T: preliminary results.
    Noebauer-Huhmann IM; Amann G; Krssak M; Panotopoulos J; Szomolanyi P; Weber M; Czerny C; Breitenseher M; Grabner G; Bogner W; Nemec S; Dominkus M; Funovics P; Windhager R; Trattnig S
    Eur Radiol; 2015 Jul; 25(7):2041-8. PubMed ID: 25577522
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Breast cancer surveillance.
    Rachetta E; Osano S; Astegiano F; Martincich L
    Minerva Ginecol; 2016 Oct; 68(5):509-16. PubMed ID: 26924173
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Correlation between quantitative and semiquantitative parameters in DCE-MRI with a blood pool agent in rectal cancer: can semiquantitative parameters be used as a surrogate for quantitative parameters?
    Dijkhoff RAP; Maas M; Martens MH; Papanikolaou N; Lambregts DMJ; Beets GL; Beets-Tan RGH
    Abdom Radiol (NY); 2017 May; 42(5):1342-1349. PubMed ID: 28050622
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Summarizing the 4D image stack of ultrafast dynamic contrast enhancement MRI of breast cancer in 3D using color intensity projections.
    Cover KS; Duvivier KM; de Graaf P; Wittenberg R; Smit R; Kuijer JPA; Hofman MBM; Slotman BJ; Verdaasdonk RM
    J Magn Reson Imaging; 2019 May; 49(5):1391-1399. PubMed ID: 30318731
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Inter-individual Comparison of Gadobutrol and Gadoteridol Tissue Time-intensity Profiles for Dynamic Susceptibility Contrast Perfusion MR Imaging.
    Yamada M; Taoka T; Kawaguchi A; Yasuda K; Niinomi Y; Ohashi Y; Okuda T; Naganawa S
    Magn Reson Med Sci; 2019 Jan; 18(1):75-81. PubMed ID: 29794406
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Accuracy of 3 T versus 1.5 T breast MRI for pre-operative assessment of extent of disease in newly diagnosed DCIS.
    Rahbar H; DeMartini WB; Lee AY; Partridge SC; Peacock S; Lehman CD
    Eur J Radiol; 2015 Apr; 84(4):611-6. PubMed ID: 25604909
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Diagnostic Value of Contrast-Enhanced Spectral Mammography in Comparison to Magnetic Resonance Imaging in Breast Lesions.
    Xing D; Lv Y; Sun B; Xie H; Dong J; Hao C; Chen Q; Chi X
    J Comput Assist Tomogr; 2019; 43(2):245-251. PubMed ID: 30531546
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparison of enhancement of the vestibular perilymph between gadoterate meglumine and gadobutrol at 3-Tesla in Meniere's disease.
    Eliezer M; Poillon G; Gillibert A; Horion J; Cruypeninck Y; Gerardin E; Magne N; Attyé A
    Diagn Interv Imaging; 2018 May; 99(5):271-277. PubMed ID: 29398574
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Comparison of Kinetic Curve between Gadodiamide Hydrate and Gadobutrol on Breast Dynamic Contrast-enhanced Magnetic Resonance Imaging in Invasive Ductal Carcinoma].
    Koori N; Kurata K; Nihashi T; Noda S; Mashita Y
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2018; 74(11):1313-1318. PubMed ID: 30464099
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Novel High Spatiotemporal Resolution Versus Standard-of-Care Dynamic Contrast-Enhanced Breast MRI: Comparison of Image Quality.
    Morrison CK; Henze Bancroft LC; DeMartini WB; Holmes JH; Wang K; Bosca RJ; Korosec FR; Strigel RM
    Invest Radiol; 2017 Apr; 52(4):198-205. PubMed ID: 27898602
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Diffusion tensor imaging for characterizing tumor microstructure and improving diagnostic performance on breast MRI: a prospective observational study.
    Luo J; Hippe DS; Rahbar H; Parsian S; Rendi MH; Partridge SC
    Breast Cancer Res; 2019 Sep; 21(1):102. PubMed ID: 31484577
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Simultaneous acquisition of MR angiography and diagnostic images of abdomen at view-sharing multiarterial phases and comparing the effect of two different contrast agents.
    Noda Y; Goshima S; Namimoto T; Shinkawa N; Nakagawa M; Kajita K; Kawada H; Kawai N; Tanahashi Y; Matsuo M; Bae KT; Hirai T; Yamashita Y
    J Magn Reson Imaging; 2018 Jul; 48(1):102-110. PubMed ID: 29247585
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Prostate diffusion-weighted imaging at 3T: effect of intravenous gadobutrol administration.
    Kim CK; Park JJ; Park BK
    Eur Radiol; 2016 May; 26(5):1450-6. PubMed ID: 26253258
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Application of whole-lesion histogram analysis of pharmacokinetic parameters in dynamic contrast-enhanced MRI of breast lesions with the CAIPIRINHA-Dixon-TWIST-VIBE technique.
    Li Z; Ai T; Hu Y; Yan X; Nickel MD; Xu X; Xia L
    J Magn Reson Imaging; 2018 Jan; 47(1):91-96. PubMed ID: 28577335
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Observer variability in the interpretation of contrast enhanced MRI of the breast.
    Mussurakis S; Buckley DL; Coady AM; Turnbull LW; Horsman A
    Br J Radiol; 1996 Nov; 69(827):1009-16. PubMed ID: 8958017
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Is there a systematic bias of apparent diffusion coefficient (ADC) measurements of the breast if measured on different workstations? An inter- and intra-reader agreement study.
    Clauser P; Marcon M; Maieron M; Zuiani C; Bazzocchi M; Baltzer PA
    Eur Radiol; 2016 Jul; 26(7):2291-6. PubMed ID: 26443604
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Evaluation of gadodiamide versus gadobutrol for contrast-enhanced MR imaging in a rat brain glioma model at 1.5 and 3 T.
    Morelli JN; Runge VM; Vu L; Loynachan AT; Attenberger UI
    Invest Radiol; 2010 Dec; 45(12):810-8. PubMed ID: 20856127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.